Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1994 8
1995 2
1996 6
1997 25
1998 49
1999 97
2000 58
2001 101
2002 108
2003 133
2004 137
2005 142
2006 180
2007 205
2008 173
2009 153
2010 191
2011 189
2012 173
2013 194
2014 219
2015 193
2016 174
2017 165
2018 153
2019 66
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

2,932 results
Results by year
Filters applied: . Clear all
Page 1
The Production of Ac-225
Engle JW. Curr Radiopharm 2018 - Review. PMID 29669509
Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
Lodi F, et al. Nucl Med Biol 2012 - Review. PMID 22172394
Several PET radiopharmaceuticals labeled with short-lived isotopes such as (18)F and (11)C were developed in order to trace specific cellular and molecular pathways with the aim of enhancing clinical applications. ...Nevertheless, the production of these radiopharmaceuticals did not reach the same level of standardization as for [(18)F]FDG synthesis. ...
Several PET radiopharmaceuticals labeled with short-lived isotopes such as (18)F and (11)C were developed in order to trace specific …
Theranostic nanoparticles
Chen F, et al. J Nucl Med 2014 - Review. PMID 25413134 Free PMC article.
Development of (225)Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences.
Robertson AKH, et al. Curr Radiopharm 2018 - Review. PMID 29658444 Free PMC article.
BACKGROUND: The development of radiopharmaceuticals containing 225Ac for targeted alpha therapy is an active area of academic and commercial research worldwide. OBJECTIVES: Despite promising results from recent clinical trials, 225Ac-radiopharmaceutical development still faces significant challenges that must be overcome to realize the widespread clinical use of 225Ac. ...
BACKGROUND: The development of radiopharmaceuticals containing 225Ac for targeted alpha therapy is an active area of academic and com …
Development of a disposable kit with fully automatic self-shielding reactor for [18F]FDG synthesis
Oh S, et al. Appl Radiat Isot 2018. PMID 29100155
A self-shielding device for the synthesis of radiopharmaceuticals was developed and fabricated in this study. Radiation exposure was minimized by the self-shielding of the kit, installation of the disposable kit in the auxiliary chamber while in a shielded state, and discharge of the kit into a radioactive waste container upon completion of the synthesis process. ...
A self-shielding device for the synthesis of radiopharmaceuticals was developed and fabricated in this study. Radiation exposure was …
2,932 results
Jump to page
Feedback